Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nidal Al-Huniti

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|October 14, 2017
Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in ChildrenWangda Zhou, Trevor N Johnson, Khanh H Bui, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 21, 2019
Population pharmacokinetic analysis of danvatirsen supporting flat dosing switchHongmei Xu, Xiao Tong, Ganesh Mugundu, et al.
Statistical Methods in Medical Research|November 1, 2018
Joint longitudinal and time-to-event models for multilevel hierarchical dataSamuel L Brilleman, Michael J Crowther, Margarita Moreno-Betancur, et al.
Clinical Pharmacology and Therapeutics|January 14, 2018
Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic UseSatyaprakash Nayak, Oliver Sander, Nidal Al-Huniti, et al.
Journal of Clinical Pharmacy and Therapeutics|April 1, 2020
Population pharmacokinetic analysis of esomeprazole in Japanese subjects with various CYP2C19 phenotypesMario Nagase, Hitoshi Shimada, Masahiro Nii, et al.
Clinical and Translational Science|July 27, 2022
A drug-disease model for predicting survival in an Ebola outbreakMasood Khaksar Toroghi, Nidal Al-Huniti, John D Davis, et al.
Clinical Therapeutics|November 14, 2016
Evaluation of the Effect of Selumetinib on Cardiac Repolarization: A Randomized, Placebo- and Positive-controlled Crossover QT/QTc Study in Healthy SubjectsDiansong Zhou, Karen So, Angela W Dymond, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 17, 2017
Drug-disease modeling in the pharmaceutical industry - where mechanistic systems pharmacology and statistical pharmacometrics meetGabriel Helmlinger, Nidal Al-Huniti, Sergey Aksenov, et al.
Clinical Pharmacology and Therapeutics|August 19, 2022
Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV-2Mohamed A Kamal, Andreas Kuznik, Luyuan Qi, et al.
Clinical Pharmacology and Therapeutics|July 16, 2021
The Posology of Dupilumab in Pediatric Patients With Atopic DermatitisMohamed A Kamal, Pavel Kovalenko, Matthew P Kosloski, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|October 14, 2017
Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in ChildrenWangda Zhou, Trevor N Johnson, Khanh H Bui, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 21, 2019
Population pharmacokinetic analysis of danvatirsen supporting flat dosing switchHongmei Xu, Xiao Tong, Ganesh Mugundu, et al.
Statistical Methods in Medical Research|November 1, 2018
Joint longitudinal and time-to-event models for multilevel hierarchical dataSamuel L Brilleman, Michael J Crowther, Margarita Moreno-Betancur, et al.
Clinical Pharmacology and Therapeutics|January 14, 2018
Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic UseSatyaprakash Nayak, Oliver Sander, Nidal Al-Huniti, et al.
Journal of Clinical Pharmacy and Therapeutics|April 1, 2020
Population pharmacokinetic analysis of esomeprazole in Japanese subjects with various CYP2C19 phenotypesMario Nagase, Hitoshi Shimada, Masahiro Nii, et al.
Clinical and Translational Science|July 27, 2022
A drug-disease model for predicting survival in an Ebola outbreakMasood Khaksar Toroghi, Nidal Al-Huniti, John D Davis, et al.
Clinical Therapeutics|November 14, 2016
Evaluation of the Effect of Selumetinib on Cardiac Repolarization: A Randomized, Placebo- and Positive-controlled Crossover QT/QTc Study in Healthy SubjectsDiansong Zhou, Karen So, Angela W Dymond, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 17, 2017
Drug-disease modeling in the pharmaceutical industry - where mechanistic systems pharmacology and statistical pharmacometrics meetGabriel Helmlinger, Nidal Al-Huniti, Sergey Aksenov, et al.
Clinical Pharmacology and Therapeutics|August 19, 2022
Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV-2Mohamed A Kamal, Andreas Kuznik, Luyuan Qi, et al.
Clinical Pharmacology and Therapeutics|July 16, 2021
The Posology of Dupilumab in Pediatric Patients With Atopic DermatitisMohamed A Kamal, Pavel Kovalenko, Matthew P Kosloski, et al.
Pageof 6